Delivery Order SPE2DB20D1047-SPE2DB25FF51H

Award Date 3/28/25
Potential Completion Date 3/31/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for Ivermectin 1% Cream in 45g tubes, with a ceiling value of $1,032.42 and a completion date of January 23, 2025. This order is placed under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ivermectin 1% cream. The contract has a ceiling value of $7,032.46 and a period of performance through April 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ivermectin 1% cream, a pharmaceutical product, with a ceiling value of $4,293.93 and a completion date of February 11, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Ivermectin 1% cream, 45 grams, valued at $2,820.78. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,552.84 firm fixed-price contract is for the delivery of Ivermectin 1% cream, a medication used to treat certain skin conditions. The contract is not designated as a set-aside and is therefore open to full and open competition. It has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp is the prime contractor and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,994.17 firm fixed-price delivery order is for 4567327835 - Ivermectin 1% Cream 45GM. The contract has an ultimate completion date of February 21, 2025 and was awarded on February 20, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
This federal contract award, with ID SPE2DB24D3013|SPE2DB25FFLMZ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ivermectin 1% cream 45g. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has a ceiling value of $1,089.69. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ivermectin 1% 45gm medication, with a ceiling value of $3,143.25 and a period of performance through May 30, 2025. The contract is a firm-fixed-price delivery order and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $2,402.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ivermectin 1% Cream, 45 gm, a pharmaceutical product, to support government medical requirements. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of May 8, 2025. The contract is not designated as a set-aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the delivery of Ivermectin 1% cream, 45 grams, with a ceiling value of $1,332.72 and a period of performance through August 7, 2024. The contract does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
  • SPE2DB20D1047
    Indefinite Delivery Contract
  • SPE2DB20D1047-SPE2DB25FF51H
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ivermectin 1% cream, 45 gm, with a ceiling value of $1,714.66 and a period of performance through March 31, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 6/27/25, 11:51 AM